{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:31:55Z","timestamp":1761561115706},"reference-count":48,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,11,17]],"date-time":"2006-11-17T00:00:00Z","timestamp":1163721600000},"content-version":"vor","delay-in-days":47,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2006,10]]},"abstract":"<jats:p><jats:bold><jats:sc>Abstract:\u2002<\/jats:sc><\/jats:bold>  <jats:bold>Synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG motifs act as immune adjuvants, improving the response elicited by a coadministered vaccine. Combining CpG ODN with anthrax vaccine adsorbed (AVA, the licensed human vaccine) increases the speed, magnitude, and avidity of the resultant antibody response. IgG Abs against anthrax protective antigen (PA) protect mice, guinuea pigs, and rhesus macaques from infection.<\/jats:bold> <\/jats:p>","DOI":"10.1196\/annals.1348.030","type":"journal-article","created":{"date-parts":[[2006,12,4]],"date-time":"2006-12-04T18:28:10Z","timestamp":1165256890000},"page":"137-150","source":"Crossref","is-referenced-by-count":36,"title":["CpG Oligonucleotides Improve the Protective Immune Response Induced by the Licensed Anthrax Vaccine"],"prefix":"10.1111","volume":"1082","author":[{"given":"DENNIS M.","family":"KLINMAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HANG","family":"XIE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BRUCE E.","family":"IVINS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,11,17]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-80451-9_2"},{"key":"e_1_2_6_3_2","first-page":"729","volume-title":"Vaccines","author":"Friedlander A.M.","year":"1998"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1201-1271"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00152686"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/iai.60.2.662-668.1992","article-title":"Immunization against anthrax with Bacilus anthracis protective antigen combined with adjuvants","volume":"60","author":"Ivins B.E.","year":"1992","journal-title":"Infect. Immun"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(99)80004-5"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-147-6-1677"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0882-4010(88)90015-0"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00387-5"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00462-5"},{"key":"e_1_2_6_12_2","first-page":"217","article-title":"Anthrax vaccination and joint related adverse reactions in light of biological warfare scenarios","volume":"20","author":"Geier D.A.","year":"2002","journal-title":"Clin. Exp. Rheumatol"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0204-112b"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00443-0"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00145-0"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.4.1659"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/374546a0"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.7.2879"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.7.3555"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/35047123"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.157.5.1840"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1996.0009"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00151-0"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830270931"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-59672-8_12"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)80122-9"},{"key":"e_1_2_6_27_2","first-page":"15","article-title":"Enhancing vaccines with immune stimulatory CpG DNA","volume":"3","author":"Krieg A.M.","year":"2001","journal-title":"Curr. Opin. Mol. Ther"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1999.00811.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.2.944"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.4.2372"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200324032"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.6.3324"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.12.020"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.2307\/2533072"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.4.2291"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-200307000-00003"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01584360"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(200003)60:3<324::AID-JMV11>3.0.CO;2-D"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0897-849"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.26.15553"},{"key":"e_1_2_6_42_2","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.4049\/jimmunol.161.9.4463","article-title":"CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice","volume":"161","author":"McCluskie M.J.","year":"1998","journal-title":"J. Immunol"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2143(96)90035-9"},{"key":"e_1_2_6_44_2","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.4049\/jimmunol.162.3.1611","article-title":"CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming","volume":"162","author":"Kovarik J.","year":"1999","journal-title":"J. Immunol"},{"key":"e_1_2_6_45_2","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4049\/jimmunol.160.2.870","article-title":"CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen","volume":"160","author":"Davis H.L.","year":"1998","journal-title":"J. Immunol"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.2.828-833.2005"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.07.004"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.71.5.813"},{"key":"e_1_2_6_49_2","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1128\/IAI.67.11.5658-5663.1999","article-title":"Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long\u2010term protection against bacterial infection","volume":"67","author":"Klinman D.M.","year":"1999","journal-title":"Infect. Immun"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1196%2Fannals.1348.030","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1196\/annals.1348.030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:15:28Z","timestamp":1695687328000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1196\/annals.1348.030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["10.1196\/annals.1348.030"],"URL":"https:\/\/doi.org\/10.1196\/annals.1348.030","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}